MedTrace Logo

Evaluation of Arginine in Periodontal and Cardiovascular Disease

NCT03873948 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 141

Last updated 2019-10-04

No results posted yet for this study

Summary

Asymmetric dimethylarginine (ADMA) plays a key role in endothelial function and may be a link for the known interaction of periodontitis and coronary heart disease (CHD). The investigators compared the impact of gingival health, periodontitis (CP), CHD or of both diseases (CP+CHD) on saliva and serum ADMA levels.

Conditions

  • Metabolic Disorder
  • Arginine; Hyperaminoaciduria

Interventions

OTHER

Evaluation of arginine serum level

correlation of serum arginine level with periodontal and cardiovascular disease

Sponsors & Collaborators

  • University of Messina

    lead OTHER

Eligibility

Min Age
19 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-01-06
Primary Completion
2018-08-08
Completion
2019-03-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03873948 on ClinicalTrials.gov